Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$10,499,812
Lobbying expense
—
Federal awards
—
Relationships
126
| $280,000 |
| — |
| lobbied by | Conafay Group On Behalf Of Antibiotics Working Group | $280,000 | — |
| lobbied by | Conafay Group On Behalf Of Antibiotics Working Group | $240,000 | — |
| lobbied by | Conafay Group On Behalf Of Antibiotics Working Group | $240,000 | — |
| lobbied by | Mind Medicine Inc. | $240,000 | — |
| lobbied by | Conafay Group On Behalf Of Antibiotics Working Group | $240,000 | — |
| lobbied by | Cempra Pharmaceuticals | $200,000 | — |
| lobbied by | Conafay Group On Behalf Of Antibiotics Working Group | $200,000 | — |
| lobbied by | Conafay Group On Behalf Of Antibiotics Working Group | $195,000 | — |
| lobbied by | Alnylam Pharmaceuticals, Inc. | $177,562 | — |
| lobbied by | Conafay Group On Behalf Of Antibiotics Working Group | $170,000 | — |
| lobbied by | Inc. Revagenix | $170,000 | — |
| lobbied by | Mind Medicine Inc. | $160,000 | Apr 20, 2026 – Jul 20, 2026 |
| lobbied by | Lifescience Logistics | $160,000 | — |
| lobbied by | Haemonetics Corporation | $160,000 | — |
| lobbied by | Wcg Wirb Copernicus Group | $150,000 | — |
| lobbied by | Inc. Durata Therapeutics | $140,000 | — |
| lobbied by | Chiesi Usa Inc | $130,000 | — |
| lobbied by | Inc. Hawaii Biotech | $130,000 | — |
| lobbied by | Inc. Atea Pharmaceuticals | $120,000 | — |
| lobbied by | Cempra Pharmaceuticals | $120,000 | — |
| lobbied by | Inc. Hawaii Biotech | $120,000 | — |
| lobbied by | Inc. Atea Pharmaceuticals | $120,000 | — |
| lobbied by | Alnylam Pharmaceuticals, Inc. | $120,000 | — |
| lobbied by | Inc. Realta Life Sciences | $120,000 | — |
| lobbied by | Inc. Atea Pharmaceuticals | $120,000 | — |
| lobbied by | Mesothelioma Applied Research Foundation | $120,000 | — |
| lobbied by | Mesothelioma Applied Research Foundation | $110,000 | — |
| lobbied by | Cempra Pharmaceuticals | $100,000 | — |
| lobbied by | Inc. Revagenix | $100,000 | Apr 20, 2026 – Jul 20, 2026 |
| lobbied by | Mesothelioma Applied Research Foundation | $100,000 | — |
| lobbied by | Inc. Atea Pharmaceuticals | $90,000 | — |
| lobbied by | Inc. Rempex Pharmaceuticals | $90,000 | — |
| lobbied by | Conafay Group Llc On Behalf Of Medicago | $90,000 | — |
| lobbied by | Bayer Healthcare | $80,000 | — |
| lobbied by | Inc. Realta Life Sciences | $80,000 | Apr 20, 2026 – Jul 20, 2026 |
| lobbied by | Acadia Pharmaceuticals Inc | $80,000 | — |
| lobbied by | Inc. Hawaii Biotech | $80,000 | — |
| lobbied by | Banner Life Sciences | $80,000 | — |
| lobbied by | Elusys Therapeutics Inc | $80,000 | — |
| lobbied by | Securing Americas Medicines And Supply Sams | $80,000 | — |
| lobbied by | Inc. Ocugen | $80,000 | — |
| lobbied by | National Tbi Registry Coalition | $80,000 | — |
| lobbied by | Inc. Roivant Sciences | $80,000 | — |
| lobbied by | Conafay Group On Behalf Of Antibiotics Working Group | $70,000 | — |
| lobbied by | Troia Therapeutics Inc. | $70,000 | — |
| lobbied by | Lifescience Logistics | $70,000 | — |